rxstat › Shortages › Hydrochlorothiazide Ramipril
Hydrochlorothiazide Ramipril shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Hydrochlorothiazide Ramipril products are in shortage in Canada (1 of 22 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jun 19, 2026.
In shortage since
Mar 11, 2026
Est. full return
Jun 19, 2026
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageTARO-RAMIPRIL HCTZ
25MG
10MG · TABLET · SUN PHARMA CANADA INC
DIN 02449471 · since Mar 11, 2026, est. end Jun 19, 2026 · Disruption of the manufacture of the drug.
ResolvedTARO-RAMIPRIL HCTZ
25MG
10MG · TABLET · SUN PHARMA CANADA INC
DIN 02449471 · ended Jan 5, 2026 · Disruption of the manufacture of the drug.
ResolvedTARO-RAMIPRIL HCTZ
25MG
10MG · TABLET · SUN PHARMA CANADA INC
DIN 02449471 · ended Oct 10, 2025 · Disruption of the manufacture of the drug.
ResolvedTARO-RAMIPRIL HCTZ
25MG
5MG · TABLET · SUN PHARMA CANADA INC
DIN 02449463 · ended Feb 10, 2025 · Disruption of the manufacture of the drug.
ResolvedTARO-RAMIPRIL HCTZ
12.5MG
10MG · TABLET · SUN PHARMA CANADA INC
DIN 02449455 · ended Jan 9, 2025 · Disruption of the manufacture of the drug.
ResolvedTARO-RAMIPRIL HCTZ
25MG
10MG · TABLET · SUN PHARMA CANADA INC
DIN 02449471 · ended Feb 23, 2024 · Disruption of the manufacture of the drug.
ResolvedTARO-RAMIPRIL HCTZ
12.5MG
5MG · TABLET · SUN PHARMA CANADA INC
DIN 02449447 · ended Feb 23, 2024 · Disruption of the manufacture of the drug.
DiscontinuedALTACE HCT
12.5MG
5MG · TABLET · BAUSCH HEALTH, CANADA INC.
DIN 02283158
DiscontinuedALTACE HCT
12.5MG
2.5MG · TABLET · BAUSCH HEALTH, CANADA INC.
DIN 02283131
DiscontinuedALTACE HCT
25MG
10MG · TABLET · BAUSCH HEALTH, CANADA INC.
DIN 02283182
DiscontinuedALTACE HCT
12.5MG
10MG · TABLET · BAUSCH HEALTH, CANADA INC.
DIN 02283166
DiscontinuedALTACE HCT
25MG
5MG · TABLET · BAUSCH HEALTH, CANADA INC.
DIN 02283174
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Hydrochlorothiazide Ramipril is currently affected by an active shortage report filed with Health Canada by SUN PHARMA CANADA INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Hydrochlorothiazide Ramipril is classified under “ACE INHIBITORS, COMBINATIONS” (ATC C09BA).
Recent changes
Common questions
When will Hydrochlorothiazide Ramipril be back in stock in Canada?
The latest manufacturer estimate is Jun 19, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Hydrochlorothiazide Ramipril in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.